Fortis Healthcare Limited (FORTIS) — Financial Results Announcement
Fortis Healthcare reported consolidated revenue of **₹9128 crores** for FY26, up 17.3% YoY, driven by 19.1% growth in hospital revenue and 8% in diagnostics, with PAT rising 31.5% to ₹1064 crores. EBITDA margin reached 22.8% for FY26, supported by 13 facilities exceeding 20% margin and 800 new beds added. Net debt stood at ₹2334 crores with a leverage ratio of 1.09x EBITDA. The company guided for 15%+ hospital revenue growth and 150 bps EBITDA margin improvement in FY27, targeting 25% margin by FY28. International business pressures from oncology drug pricing and reduced patient volumes are being offset by domestic expansion, including 500+ bed additions by FY27 and INR900 crore annual capex. Digital health efforts remain focused on internal platform enhancements rather than external partnerships.
📄 View Original Announcement (PDF)
About Fortis Healthcare Limited (FORTIS)
Healthcare · Healthcare Services · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.